Invasive lobular carcinoma of the breast
Citation, DOI & article data
Invasive lobular carcinoma is the most common special type of invasive breast cancer after invasive breast carcinoma of no special type (invasive ductal carcinoma not otherwise specified).
They represent 5-10% of all breast cancer.
There is a greater rate of contralateral breast cancer in invasive lobular carcinoma compared with invasive carcinoma of no special type, with a 5-year rate of bilateral cancer of 8% (4% synchronous and 4% metachronous tumors).
Invasive lobular carcinoma is characterized microscopically by malignant monomorphic cells that form loosely dispersed linear columns that invade the normal tissues and encircle ducts. Compare this behavior with that of invasive carcinoma of no special type (ductal not otherwise specified), which more commonly presents as a mass with vigorous desmoplastic response. Cells of invasive lobular carcinoma often preserve the architecture of the ducts, which limits the sensitivity of detection using mammography.
Most invasive lobular carcinomas are grade 2 in the Nottingham histological grading system 13.
Loss of E-cadherin is a specific biomarker for invasive lobular carcinoma as opposed to invasive breast carcinoma of no special type, although 15% of invasive lobular carcinoma are positive for E-cadherin 13.
The majority of invasive lobular carcinomas have the following receptor profile 12:
- estrogen receptor: positive
- progesterone receptor: positive
- HER2 amplification: negative
Invasive lobular carcinoma is more often multicentric and bilateral (10-15%). Therefore imaging evaluation of the contralateral breast is crucial. There can be very subtle changes such as progressive shrinkage or enlargement or reduced compressibility of the involved breast 9. Imaging often underestimates the disease.
The sensitivity of mammography for the detection of Invasive lobular carcinoma reportedly ranges between 57-81% 8. Because of the limitations of mammography in detecting ILC, other modalities, such as sonography and MR imaging, are being used in evaluating clinically suspicious findings and known cancers to assess the extent of disease. Invasive lobular carcinomas are more commonly seen on the craniocaudal (CC), compared to the mediolateral oblique (MLO).
Mammographic findings in order of frequency are:
- spiculated mass lesion (most common)
- asymmetrical densities (3-25% 6)
- opacities or architectural distortions (10-25% 6)
- microcalcifications (<10% 1)
- 16% of invasive lobular carcinoma are mammographically occult or benign
The most common sonographic appearance is that of a heterogeneous, hypoechoic mass with angular or ill-defined margins and posterior acoustic shadowing. An ill-defined heterogenous infiltrating area of low echogenicity with disproportionate posterior shadowing is one of the sonographic characteristics of invasive lobular carcinoma.
Due to its propensity for multicentricity, breast MRI is usually recommended in many countries when histology of a lesion reveals invasive lobular carcinoma.
Treatment and prognosis
Despite the difficulties of mammographic diagnosis and the propensity for multiplicity and bilaterality, the overall survival rate for patients with invasive lobular carcinoma of a given size and stage is believed to be slightly higher than for patients with invasive ductal carcinomas 8. Due to the diffuse invasive nature of this tumor, positive resection margins can be common.
History and etymology
It is thought to have been first described by Cornil in 1865 10.
- 1. Jafri, Nazia F; Slanetz, Priscilla J. Radiology Case Reports. doi:10.2484/rcr.v2i3.94
- 2. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161 (5): 957-60. AJR Am J Roentgenol (abstract) - Pubmed citation
- 3. Gill HK, Berg WA. Case 39: invasive lobular carcinoma. Radiology. 2001;221 (1): 132-6. doi:10.1148/radiol.2211991748 - Pubmed citation
- 4. Brem RF, Ioffe M, Rapelyea JA et-al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol. 2009;192 (2): 379-83. doi:10.2214/AJR.07.3827 - Pubmed citation
- 5. Conant EF, Brennecke CM. Breast imaging, case review. Mosby Inc. (2006) ISBN:0323017460. Read it at Google Books - Find it at Amazon
- 6. Evans WP, Warren burhenne LJ, Laurie L et-al. Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection. Radiology. 2002;225 (1): 182-9. doi:10.1148/radiol.2251011029 - Pubmed citation
- 7. Yeh ED, Slanetz PJ, Edmister WB et-al. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J. 9 (1): 13-8. Breast J (link) - Pubmed citation
- 8. Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 29 (1): 165-76. doi:10.1148/rg.291085100 - Pubmed citation
- 9. Cardeñosa G. Clinical breast imaging, a patient focused teaching file. Lippincott Williams & Wilkins. (2006) ISBN:0781762677. Read it at Google Books - Find it at Amazon
- 10. Paredes ES. Atlas of mammography. Lippincott Williams & Wilkins. (2007) ISBN:0781764335. Read it at Google Books - Find it at Amazon
- 11. Singhai R, Patil VW, Jaiswal SR et-al. E-Cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci. 2011;3 (5): 227-33. doi:10.4297/najms.2011.3227 - Free text at pubmed - Pubmed citation
- 12. Yu J, Dabbs DJ, Shuai Y et-al. Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics. Am. J. Clin. Pathol. 2011;136 (1): 88-97. doi:10.1309/AJCP7URIW0QETTAT - Pubmed citation
- 13. Sinn HP, Kreipe H. A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. (2013) Breast care (Basel, Switzerland). 8 (2): 149-54. doi:10.1159/000350774 - Pubmed - Pubmed Central